Study backs fourth jab to protect blood cancer patients from Omicron
Three doses of vaccine have only given 56% of that high-risk group antibodies to repel the Covid-19 variant
Full Article
Study backs fourth jab to protect blood cancer patients from Omicron
Wales Online
0 shares
2 views
You might like
Related news coverage
Omicron variant poses 'greater risk' to blood cancer patients, experts warn
Daily Record
Researchers are now urging the examination of the effects of a fourth booster after carrying out extensive research.
